Suppr超能文献

含咖啡因作为模型药物的肠道压力控制结肠递送胶囊在人类志愿者中的评估。

Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers.

作者信息

Muraoka M, Hu Z, Shimokawa T, Sekino S, Kurogoshi R, Kuboi Y, Yoshikawa Y, Takada K

机构信息

Department of Pharmaceutics and Pharmacokinetics, Kyoto Pharmaceutical University, Japan.

出版信息

J Control Release. 1998 Mar 2;52(1-2):119-29. doi: 10.1016/s0168-3659(97)00201-0.

Abstract

The delivery ability of a pressure-controlled colon delivery capsule (PCDC) containing caffeine as a test drug was evaluated after oral administration to healthy male human volunteers. The driving force causing PCDC disintegration in the intestinal tract is the physiological luminal pressure which results from peristalsis. Three kinds of PCDCs having different thickness of a water-insoluble polymer membrane was prepared by coating the inner surface of the gelatin capsules with ethylcellulose (EC). The mean thickness were 40 +/- 1 (SE) for type 1, 44 +/- 1 for type 2 and 50 +/- 1 micron for type 3 PCDC, respectively. Caffeine was dissolved with a suppository base (PEGs 400 and 1000) and the capsules were filled. Doses were 15, 45 or 75 mg. After blank saliva samples were obtained, test preparations were orally administered to the volunteers and saliva samples were collected for 1 min intervals hourly from 1 to 10 h in the fasted state study, and from 1 to 20 h and at 25 h in the fed state study. Caffeine concentrations in the saliva samples were analyzed by HPLC. The maximum salivary caffeine excretion rate increased as the oral caffeine dose increased. The maximum salivary caffeine excretion rate increased predominantly compared to the pre-dose level in 75 mg dose study. Therefore, all following studies were performed with this dose. The first appearance time of caffeine into the saliva, TI, was used as a parameter to estimate the disintegration time of test preparations in the gastrointestinal tract. The mean TI of types 1, 2, and 3 PCDCs were 3.0 +/- 0.4, 4.0 +/- 0.4 and 4.5 +/- 0.3 h, respectively. After oral administration of 75 mg caffeine in pain gelatin capsule as a reference preparation, caffeine appeared in the saliva within 0.5 h. The mean hardness of the PCDCs were 1.05 +/- 0.10 (type 1), 1.55 +/- 0.06 (type 2) and 2.08 +/- 0.15 newton (type 3), respectively. There were good correlations between three parameters: EC coating membrane thickness, hardness and TI (determination coefficient r2 = 0.935 between TI and thickness, r2 = 0.998 between thickness and hardness, r2 = 0.958 between hardness and TI). The effect of food intake on the delivery ability was examined with type 3 PCDCs. Food intake prolonged the mean TI, from 4.5 +/- 0.3 to 7.8 +/- 1.3 h. This increase is thought to be ascribed to prolonged gastric emptying time. Comparison with reported colon arrival times indicates that the type 3 PCDC functions in colon delivery of caffeine and is thought to be applicable to other drugs.

摘要

以咖啡因作为受试药物,对健康男性志愿者口服给药后,评估了含咖啡因的压力控制型结肠给药胶囊(PCDC)的给药能力。导致PCDC在肠道内崩解的驱动力是由蠕动产生的生理腔内压力。通过用乙基纤维素(EC)包被明胶胶囊的内表面,制备了三种具有不同厚度水不溶性聚合物膜的PCDC。1型、2型和3型PCDC的平均厚度分别为40±1(标准误)、44±1和50±1微米。咖啡因与栓剂基质(聚乙二醇400和1000)溶解后填充胶囊。剂量分别为15、45或75毫克。采集空白唾液样本后,将受试制剂口服给予志愿者,在禁食状态研究中,于1至10小时每小时间隔1分钟采集唾液样本,在进食状态研究中,于1至20小时以及25小时采集唾液样本。通过高效液相色谱法分析唾液样本中的咖啡因浓度。唾液中咖啡因的最大排泄率随口服咖啡因剂量的增加而增加。在75毫克剂量研究中,与给药前水平相比,唾液中咖啡因的最大排泄率显著增加。因此,所有后续研究均采用该剂量进行。咖啡因首次出现在唾液中的时间TI被用作评估受试制剂在胃肠道中崩解时间的参数。1型、2型和3型PCDC的平均TI分别为3.0±0.4、4.0±0.4和4.5±0.3小时。以疼痛明胶胶囊口服75毫克咖啡因作为参比制剂,咖啡因在0.5小时内出现在唾液中。PCDC的平均硬度分别为1.05±0.10(1型)、1.55±0.06(2型)和2.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验